Pituitary‐adrenal function after prolonged use of topical corticosteroids

British Journal of Dermatology

Volumn 88, Issue 4, 1973, Pages 381-385

  MUNRO, D D ^a,b   CLIFT, D C ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Edgware Community Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETAMETHASONE; CORTICOSTEROID; FLUOCINOLONE; HYDROCORTISONE;

ADRENAL SUPPRESSION; ADVERSE DRUG REACTION; ECZEMA; HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; PHARMACOLOGY; PSORIASIS; SKIN DISEASE; THERAPY; TOPICAL DRUG ADMINISTRATION;

11-HYDROXYCORTICOSTEROIDS; ADOLESCENT; ADRENAL GLANDS; ADULT; AGED; BETAMETHASONE; BLOOD GLUCOSE; CHILD; ECZEMA; FEMALE; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS, TOPICAL; HUMAN; INSULIN; MALE; MIDDLE AGE; PITUITARY GLAND; PSORIASIS; SKIN DISEASES; TIME FACTORS;

EID: 0015907587     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1973.tb07569.x     Document Type: Article

References (12)

1. Effect of topically applied 0.1% betamethasone 17‐valerate (‘Betnovate’) ointment on the adrenal function of children
2. The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin
3. Pituitary‐adrenal function after occlusive topical therapy with betamethasone‐17‐valerate
4. Topical corticosteroid preparations–hazards and side‐effects
5. The influence of topical corticosteroids on hypothalamic‐pituitary–adrenal function
6. Complications of topical corticosteroid therapy
7. Decrease of urinary corticosteroids following application of fluocinolone acetonide under an occlusive dressing
8. Percutaneous absorption of corticosteroids
9. Some quantitative factors in topical corticosteroid therapy
10. Local corticosteroids in dermatology
11. Plasma corticosteroid levels in out‐patients treated with topical steroids